InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.6653
-0.0050 (-0.75%)
At close: Apr 2, 2026, 4:00 PM EDT
0.6780
+0.0127 (1.91%)
After-hours: Apr 2, 2026, 4:04 PM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$346,661
Profits / Employee
-$589,566
Market Cap
2.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2024 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2023 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2022 | 13 | 1 | 8.33% | 13 | 0 |
| Jun 30, 2021 | 12 | 0 | - | 12 | 0 |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsINM News
- 6 days ago - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance - Newsfile Corp
- 10 days ago - InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program - Newsfile Corp
- 24 days ago - InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial - Newsfile Corp
- 27 days ago - InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Newsfile Corp
- 7 weeks ago - InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - InMed Announces Results of 2025 Annual General and Special Meeting - Newsfile Corp
- 3 months ago - InMed Provides Update on BayMedica Commercial Business - Newsfile Corp
- 4 months ago - InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 - Newsfile Corp